Semaglutide is a GLP-1 receptor agonist and tirzepatide is a dual GIP and GLP-1 receptor agonist. In head-to-head trials, tirzepatide produced greater average weight loss (about 20 to 22 percent of body weight at higher doses) than semaglutide (about 13 to 16 percent), though results vary and semaglutide has the longer cardiovascular track record and an oral option.
At Vitality Medical in Lynnwood, WA, both are provider-guided by Dr. Erik Marks, DNP, ARNP and all-inclusive: semaglutide is $290 per month and tirzepatide is $350 per month, each covering visits, medication up to max dosing, and labs before and after. The right choice depends on your goals, tolerance, and history. Call (425) 216-8280.
Key takeaways
- Semaglutide is a GLP-1 receptor agonist, and tirzepatide is a dual GIP and GLP-1 receptor agonist. That difference in mechanism is the heart of the comparison.
- In head-to-head trials, tirzepatide produced greater average weight loss (roughly 20 to 22 percent of body weight at higher doses) than semaglutide (roughly 13 to 16 percent), though individual results vary.
- Semaglutide has the longer track record and the strongest cardiovascular outcome data, and it comes as an injection or an oral tablet. Tirzepatide is injection only.
- Both share similar gastrointestinal side effects and the same class warnings, so tolerance and medical history matter as much as the raw numbers.
- At Vitality Medical in Lynnwood, WA, both are offered as all-inclusive, provider-guided programs: semaglutide at $290 per month and tirzepatide at $350 per month, including visits, medication up to max dosing, and labs before and after.
Semaglutide and tirzepatide are the two names almost everyone researches before starting a medical weight loss program, and the internet is full of headlines declaring one the winner. The honest answer is more useful than a winner: these are two effective, once-weekly injectable medications that work through different biology, and the better choice depends on your goals, your tolerance, and your medical history. This guide walks through how each one works, how they compare on weight loss and side effects, what they cost, and how to decide, all in plain language and backed by a provider-guided program.
What is the difference between semaglutide and tirzepatide?
The core difference is how many hormone pathways each medication activates. Semaglutide is a single-hormone GLP-1 receptor agonist, while tirzepatide is a dual-hormone agonist that targets both GIP and GLP-1 receptors. That second pathway is why tirzepatide tends to produce greater average weight loss in clinical trials.
The main difference is mechanism: semaglutide activates one hormone pathway (GLP-1), while tirzepatide activates two (GIP and GLP-1), which is why tirzepatide tends to produce greater average weight loss in clinical trials.
Both are sold under brand names you have probably heard. Semaglutide is the active ingredient in Ozempic and Wegovy (and the oral tablet Rybelsus). Tirzepatide is the active ingredient in Mounjaro and Zepbound. For weight management, what matters is the active ingredient and the program around it, not the brand on the box.
How does each medication work?
Both medications mimic gut hormones that your body releases after you eat, which is why they reduce appetite and help regulate blood sugar. The difference is how many of those hormone signals each one copies.
Semaglutide (GLP-1)
Semaglutide imitates glucagon-like peptide-1 (GLP-1), a hormone that signals fullness to the brain, slows how quickly the stomach empties, and prompts the pancreas to release insulin when blood sugar rises. The result is less hunger, smaller portions, and steadier blood sugar.
Tirzepatide (GIP and GLP-1)
Tirzepatide does everything semaglutide does on the GLP-1 pathway and adds a second signal, glucose-dependent insulinotropic polypeptide (GIP). Acting on both receptors appears to give tirzepatide a broader effect on appetite and how the body handles fat and insulin, which helps explain its larger average weight-loss numbers.
Which one causes more weight loss?
On average, tirzepatide produces greater weight loss than semaglutide, though both are highly effective and individual results vary. In head-to-head and comparative trials, tirzepatide at its higher doses has led to roughly 20 to 22 percent average body-weight reduction, compared with roughly 13 to 16 percent for semaglutide.
In clinical trials, tirzepatide has produced greater average weight loss (about 20 to 22 percent of body weight at higher doses) than semaglutide (about 13 to 16 percent), but results vary from person to person and depend on dose, diet, and consistency.
Two things keep those averages in perspective. First, trial averages are not promises: your result depends on your starting point, your dose, how well you tolerate the medication, and the habits you build alongside it. Second, more weight loss on paper is not automatically the right goal for every patient, which is where a provider-guided plan matters.
How do the side effects compare?
Both medications share the same main side effects, which are gastrointestinal: nausea, vomiting, diarrhea, constipation, and fatigue, usually most noticeable while the dose is being increased. The two differ more in the pattern than the type of side effect.
In practice, semaglutide tends to be associated more with nausea and constipation, while tirzepatide more often causes diarrhea. Some people who struggled with nausea on one medication tolerate the other better, which is one reason the choice is individual rather than universal. Most side effects ease as your body adjusts and as the dose is raised gradually (a process called titration) rather than all at once.
- Start low, go slow: gradual dose increases are the main way to limit side effects.
- Hydration and meal size: smaller meals and steady fluids help with the early GI effects.
- Tell your provider: persistent or severe symptoms are a reason to adjust the plan, not to push through alone.
Which is safer, and are there warnings?
Both medications are considered safe for appropriate candidates under medical supervision, and they carry the same major warnings, so safety comes down to proper screening rather than one being broadly safer than the other. Semaglutide does have the longer and more established cardiovascular outcome record.
Key safety points that apply to both:
- Both carry a boxed warning about a risk of thyroid C-cell tumors seen in animal studies, and neither should be used by people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2.
- Neither is used during pregnancy, and both call for caution in people with a history of pancreatitis or severe gastrointestinal conditions such as gastroparesis.
- Semaglutide has mature trial evidence showing cardiovascular benefit, while tirzepatide’s cardiovascular outcome studies are still maturing.
This is exactly the kind of screening a qualified provider handles before you start, and it is why these medications are prescription-only rather than something to source on your own.
Why does tirzepatide cost more than semaglutide?
Tirzepatide is generally priced higher than semaglutide, largely because it is a newer, dual-action medication. What you actually pay, though, depends far more on the program you choose than on the molecule, because pricing models differ widely between clinics.
At Vitality Medical PNW, both are offered as all-inclusive monthly programs, so the price you see covers your care rather than just the first visit:
| Program | Vitality Medical price | What is included |
|---|---|---|
| Semaglutide | $290 per month | All visits, medication up to max dosing, and labs before and after |
| Tirzepatide | $350 per month | All visits, medication up to max dosing, and labs before and after |
At Vitality Medical PNW, semaglutide and tirzepatide are offered as all-inclusive programs at $290 and $350 per month, each including provider visits, medication up to maximum dosing, and lab work before and after.
Semaglutide vs. tirzepatide at a glance
| Factor | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 (single hormone) | GIP and GLP-1 (dual hormone) |
| Average weight loss | About 13 to 16 percent | About 20 to 22 percent |
| Form | Weekly injection or oral tablet | Weekly injection only |
| Common side effects | More nausea, constipation | More diarrhea |
| Track record | Longer, strong cardiovascular data | Newer, outcome studies maturing |
| Vitality monthly price | $290, all-inclusive | $350, all-inclusive |
How do you choose between them?
The right choice is the one that fits your goals, your tolerance, and your medical history, which is a decision to make with a provider rather than from a headline. More weight loss on average does not automatically mean tirzepatide is right for you, and the longer track record does not automatically mean semaglutide is.
In a provider-guided program, the factors that usually drive the decision include your weight-loss goal, how your body tolerates the medication, whether you prefer or need an oral option, your personal and family medical history, and cost. Many patients also start on one medication and adjust later based on results and tolerance, which is normal and part of good management.
What results can you expect, and how fast?
Both medications work gradually, with appetite changes often noticeable within the first few weeks and meaningful weight loss building over several months as the dose is increased. Neither is an overnight solution, and both work best alongside nutrition and activity changes.
Because the dose is raised slowly to limit side effects, the early weeks are about adjustment more than dramatic results. The larger changes come over the following months, which is why consistent follow-up and lab monitoring are part of a well-run program. At Vitality Medical PNW, medical weight loss is provider-guided by Dr. Erik Marks, DNP, ARNP, with labs before and after and dose management along the way, so your plan is matched to how your body actually responds. If you want to know which option fits your goals, a consultation can walk you through it. You can request a weight loss consultation in Lynnwood, WA whenever you are ready.
To go deeper on either medication, see our semaglutide peptide therapy for weight loss and tirzepatide weight loss injections pages. You can also compare the full program on our medical weight loss hub, and if your weight has stalled despite effort, read about hormone therapy for weight loss resistance.
Frequently asked questions
What is the difference between semaglutide and tirzepatide?
Semaglutide activates one hormone pathway (GLP-1), while tirzepatide activates two (GIP and GLP-1). The dual action is why tirzepatide tends to produce greater average weight loss, though both are effective and the right choice depends on the individual.
Which is better for weight loss, semaglutide or tirzepatide?
On average, tirzepatide produces greater weight loss in clinical trials, roughly 20 to 22 percent of body weight at higher doses versus roughly 13 to 16 percent for semaglutide. Even so, both are highly effective, and the better choice depends on your goals, tolerance, and medical history.
Why is tirzepatide more expensive than semaglutide?
Tirzepatide is generally priced higher because it is a newer, dual-action medication. At Vitality Medical PNW, semaglutide is $290 per month and tirzepatide is $350 per month, each all-inclusive of visits, medication up to max dosing, and labs.
Can I switch from one to the other?
Many patients adjust between medications based on results and tolerance, and that switch is a normal part of provider-guided management. It should always be done with your provider, who will manage the transition and dosing.
How fast do you lose weight on tirzepatide?
Appetite changes are often noticeable within the first few weeks, while meaningful weight loss builds over several months as the dose is increased. Results vary by person and are strongest when paired with nutrition and activity changes.
What is compounded tirzepatide?
Compounded tirzepatide is a version prepared by a compounding pharmacy rather than the branded manufacturer. Whether it is appropriate for you is a clinical decision, and any weight-loss medication should be used only under provider supervision with proper labs and monitoring.